Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

30.25
+0.83002.82%
Post-market: 30.680.4289+1.42%18:21 EDT
Volume:3.29M
Turnover:97.88M
Market Cap:2.17B
PE:-5.13
High:30.61
Open:29.09
Low:28.46
Close:29.42
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.72
T/O Rate:6.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.32
PE(LYR):-6.49

Loading ...

Vera Therapeutics Announces Trutakna™ (Atacicept-Vymj) Stabilized Egfr and Prevented Kidney Disease Progression Through Two Years in Origin 3 Final Efficacy Analysis in Iga Nephropathy

THOMSON REUTERS
·
Sep 15

Vera Therapeutics, - Trutakna Meets All Prespecified Endpoints in Origin 3 Final Efficacy Analysis

THOMSON REUTERS
·
Sep 15

Vera Therapeutics is Maintained at Overweight by JP Morgan

Dow Jones
·
Sep 08

U.S. Research Roundup-Fedex Freight Holding Company, PDF Solutions, Robinhood Markets

Reuters
·
Sep 08

Vera Therapeutics, Inc. : JP Morgan Raises Target Price to $83 from $76

THOMSON REUTERS
·
Sep 08

Vera Therapeutics CEO Fordyce Marshall Disposes of USD 649,642 Common Shares

Reuters
·
Sep 05

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

Vera Therapeutics Management Presents at Cantor Global Healthcare Conference 2026

Reuters
·
Sep 01

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts

TIPRANKS
·
Aug 25

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 18

Vera Therapeutics Price Target Maintained with a $34.00/Share by Wedbush

Dow Jones
·
Aug 17

Vera Rises on Early Kidney Function Data in FDA Review

Reuters
·
Aug 15

Analyst Maintains Buy on Vera Therapeutics, Cutting Trutakna Price Target to $90 Amid Rising IgAN Competition

TIPRANKS
·
Aug 12

Analyst Sees Vera Well Positioned for Trutakna IgAN Launch, Sustained Uptake and Long‑Term Value Creation

TIPRANKS
·
Aug 12

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 11

Vera Therapeutics Price Target Cut to $34.00/Share from $43.00 by Wedbush

Dow Jones
·
Aug 11

Vera Therapeutics, Inc. : Wedbush Cuts Target Price to $34 from $43

THOMSON REUTERS
·
Aug 11

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $43, Maintains Neutral Rating

MT Newswires Live
·
Aug 11

Vera Therapeutics (VERA) Gets a Buy from Bank of America Securities

TIPRANKS
·
Aug 11